MyFinsight
Home
Blog
About
Contact
Download
Download image
Locations Excluding The
United States And...
$308,482K
(12.99%↑ Y/Y)
US
$275,859K
(13.77%↑ Y/Y)
Europe
$201,044K
(19.65%↑ Y/Y)
US
$463,602K
(5.12%↑ Y/Y)
Europe
$65,023K
(18.44%↑ Y/Y)
Locations Excluding The
United States And...
$64,187K
(10.09%↑ Y/Y)
Cardiopulmonary
Segment-Operating Segments
$785,385K
(14.90%↑ Y/Y)
Neuromodulation
Segment-Operating Segments
$592,812K
(6.96%↑ Y/Y)
Corporate Non Segment
$9,856K
Net revenue
$1,388,053K
(10.74%↑ Y/Y)
Net (loss) income
-$242,471K
(-483.45%↓ Y/Y)
Gross profit
$939,870K
(7.92%↑ Y/Y)
Cost of sales
$448,183K
(17.15%↑ Y/Y)
(loss) income before
income tax
-$220,781K
(-350.01%↓ Y/Y)
Income tax expense
(benefit)
$21,639K
(-13.64%↓ Y/Y)
Loss from equity
method investments
-$51K
(-183.33%↓ Y/Y)
Operating income (loss)
$199,390K
(54.50%↑ Y/Y)
Selling, general, and
administrative
$548,813K
(4.28%↑ Y/Y)
Research and development
$185,764K
(1.78%↑ Y/Y)
Other operating
expense
-$5,903K
(82.14%↑ Y/Y)
Snia environmental
liability expense
$365,553K
Interest expense
$49,286K
(-21.86%↓ Y/Y)
Foreign exchange and
other...
-$2,681K
(-105.61%↓ Y/Y)
Loss on debt
extinguishment
-$2,651K
(89.60%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LivaNova PLC (LIVN)
LivaNova PLC (LIVN)